60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial

Go back to 60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
(NASDAQ: SXTP) Delayed: 1.71 -0.04 (2.29%)
Previous Close $1.75    52 Week High
Open $1.67    52 Week Low
Day High $1.82    P/E N/A 
Day Low $1.67    EPS
Volume 24,775       

(NASDAQ: SXTPW) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High
Open $0.03    52 Week Low
Day High $0.03    P/E N/A 
Day Low $0.03    EPS
Volume 60,785